You are here

Article info

Article menu

Download PDFPDF

Section 6: Education and research
6ER-008 Development of a risk-sharing model based on the clinical performance of onasemnogene abeparvovec (Zolgensma)
Free

Authors

Citation

Martins De Figueiredo A, Pinheiro Gonçalves Marques R, Martins Silvestre Correia AMDA, et al
6ER-008 Development of a risk-sharing model based on the clinical performance of onasemnogene abeparvovec (Zolgensma)
European Journal of Hospital Pharmacy 2022;29:A170.

Publication history

  • First published March 23, 2022.
Online issue publication 
April 22, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.